EP0591320A4 - Hybridome de cellules t suppressives. - Google Patents

Hybridome de cellules t suppressives.

Info

Publication number: EP0591320A4
Authority: EP; European Patent Office
Prior art keywords: hybridom; suppressor; cells
Prior art date: 1991-06-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

EP19920913077

Other languages

German (de)

English (en)

Other versions

EP0591320A1 (fr

Inventor

Ishizaka Kimishige

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

La Jolla Institute for Allergy and Immunology

Original Assignee

La Jolla Institute for Allergy and Immunology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-03

Filing date

1992-06-03

Publication date

1994-11-23

1992-06-03 Application filed by La Jolla Institute for Allergy and Immunology filed Critical La Jolla Institute for Allergy and Immunology

1994-04-13 Publication of EP0591320A1 publication Critical patent/EP0591320A1/fr

1994-11-23 Publication of EP0591320A4 publication Critical patent/EP0591320A4/fr

Status Ceased legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Transplantation (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

EP19920913077 1991-06-03 1992-06-03 Hybridome de cellules t suppressives. Ceased EP0591320A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US70937591A	1991-06-03	1991-06-03
US709375		1991-06-03
PCT/US1992/004614 WO1992021240A1 (fr)	1991-06-03	1992-06-03	Hybridome de cellules t suppressives

Publications (2)

Publication Number	Publication Date
EP0591320A1 EP0591320A1 (fr)	1994-04-13
EP0591320A4 true EP0591320A4 (fr)	1994-11-23

Family

ID=24849607

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19920913077 Ceased EP0591320A4 (fr)	1991-06-03	1992-06-03	Hybridome de cellules t suppressives.

Country Status (8)

Country	Link
EP (1)	EP0591320A4 (fr)
JP (1)	JPH06508829A (fr)
AU (1)	AU2161792A (fr)
CA (1)	CA2103046A1 (fr)
FI (1)	FI934989A7 (fr)
HU (1)	HUT67010A (fr)
NO (1)	NO934382L (fr)
WO (1)	WO1992021240A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3578787B2 (ja) *	1993-05-14	2004-10-20	ラホヤインスティチュートフォアアレルギーアンドイムノロジー	生物学的に活性なポリペプチドの組換え製造方法
JP6147340B2 (ja) *	2013-05-29	2017-06-14	Jsr株式会社	洗浄用組成物、タンパク質精製方法、及びタンパク質

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4946788A (en) *	1985-06-11	1990-08-07	Ciba-Geigy Corporation	Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
EP0285405A1 (fr) *	1987-03-31	1988-10-05	Schering Biotech Corporation	Facteur d'inhibition de la glycosylation

1992
- 1992-06-03 HU HU9303380A patent/HUT67010A/hu unknown
- 1992-06-03 CA CA002103046A patent/CA2103046A1/fr not_active Abandoned
- 1992-06-03 JP JP5500618A patent/JPH06508829A/ja active Pending
- 1992-06-03 EP EP19920913077 patent/EP0591320A4/fr not_active Ceased
- 1992-06-03 FI FI934989A patent/FI934989A7/fi not_active Application Discontinuation
- 1992-06-03 WO PCT/US1992/004614 patent/WO1992021240A1/fr not_active Ceased
- 1992-06-03 AU AU21617/92A patent/AU2161792A/en not_active Abandoned
1993
- 1993-12-02 NO NO934382A patent/NO934382L/no unknown

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
C. CARINI ET AL.: "A METHOD TO GENERATE ANTIGEN-SPECIFIC SUPPRESSOR T CELLS IN VITRO FROM PERIPHERAL BLOOD T CELLS OF HONEY BEE VENOM-SENSITIVE, ALLERGIC PATIENTS.", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 127, no. 2, 9 March 1990 (1990-03-09), NEW YORK US, pages 221 - 233 *
M. IWATA ET AL.: "RELATIONSHIP BETWEEN T CELL RECEPTORS AND ANTIGEN-BINDING FACTORS. I. SPECIFICITY OF FUNCTIONAL T CELL RECEPTORS ON MOUSE T CELL HYBRIDOMAS THAT PRODUCE ANTIGEN-BINDING T CELL FACTORS.", JOURNAL OF IMMUNOLOGY., vol. 143, no. 12, 15 December 1989 (1989-12-15), BALTIMORE US, pages 3909 - 3916 *
P. THOMAS ET AL.: "GLYCOSYLATION-INHIBITING FACTOR FROM HUMAN T CELL HYBRIDOMAS CONSTRUCTED FROM PERIPHERAL BLOOD LYMPHOCYTES OF A BEE VENOM-SENSITIVE ALLERGIC PATIENT.", JOURNAL OF IMMUNOLOGY., vol. 148, no. 3, 1 February 1992 (1992-02-01), BALTIMORE US, pages 729 - 737 *
See also references of WO9221240A1 *

Also Published As

Publication number	Publication date
WO1992021240A1 (fr)	1992-12-10
CA2103046A1 (fr)	1992-12-04
FI934989A0 (fi)	1993-11-11
HU9303380D0 (en)	1994-03-28
EP0591320A1 (fr)	1994-04-13
NO934382D0 (no)	1993-12-02
NO934382L (no)	1994-02-02
FI934989L (fi)	1993-12-01
HUT67010A (en)	1995-01-30
FI934989A7 (fi)	1993-12-01
AU2161792A (en)	1993-01-08
JPH06508829A (ja)	1994-10-06

Legal Events

Date	Code	Title	Description
1994-02-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1994-04-13	17P	Request for examination filed	Effective date: 19931230
1994-04-13	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1994-10-26	RHK1	Main classification (correction)	Ipc: C12P 21/00
1994-11-23	A4	Supplementary search report drawn up and despatched	Effective date: 19941004
1994-11-23	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1997-02-05	17Q	First examination report despatched	Effective date: 19961219
2000-05-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED
2000-07-05	18R	Application refused	Effective date: 20000425

Publication	Publication Date	Title
DE3480930D1 (de)	1990-02-08	Atriale peptide.
DE3878965D1 (de)	1993-04-15	Schaltregler.
DE3685394D1 (de)	1992-06-25	Zweimodem-videotracker.
DE69201259D1 (de)	1995-03-09	Elektrotauchlackierungszusammensetzung.
FI906202A0 (fi)	1990-12-17	Obemannat disksystem.
FI834345L (fi)	1984-06-04	Substituerade tetrapeptider.
FI841801A0 (fi)	1984-05-04	Anordning i en pappersmaskin vid styrning av banans aendfoeringsband.
FI851326A0 (fi)	1985-04-02	Foerfarande foer minskning av icke specifika stoerningar vid agglutinationsimmunoanalyser.
DE69104947D1 (de)	1994-12-08	Verhütung von Kesselstein.
DE69204290D1 (de)	1995-09-28	Verwendung von 1,2,2,3,3-pentafluorpropan.
FI892677L (fi)	1989-12-07	Polypeptidfoereningar.
ITMI912655A1 (it)	1993-04-07	Combinazione di estrusore-calandra.
NL192123B (nl)	1996-10-01	Manifestatiecomplex.
FI914255L (fi)	1992-03-18	I uv-ljus haerdbar organopolysil- oxankomposition.
DE69206081D1 (de)	1995-12-21	Stabilisierte Polyolefinzusammensetzung.
FI923709A0 (fi)	1992-08-19	I en saekerhetsskena laosbar vagn.
DE59204051D1 (de)	1995-11-23	Verwendung von polymodalem beta-Oktogen.
FI832620A7 (fi)	1984-01-20	Substituoituja peptidiyhdisteitä.
DE69208681D1 (de)	1996-04-04	Verwendungen von 1,1,1,3,3,3-hexafluoropropan
EP0591320A4 (fr)	1994-11-23	Hybridome de cellules t suppressives.
MX9201395A (es)	1992-10-01	Construccion de bloque de dintel.
MX9200872A (es)	1992-09-01	Composicion de bis-bibenzimidazol.
FI885737A0 (fi)	1988-12-09	Anordning vid pressparti i en pappersmaskin.
FI896131A0 (fi)	1989-12-20	Hoegresolutions television.
FI851064L (fi)	1986-04-20	Saett och anordning vid plasmageneratorinstallation i schaktugn.